Aktienbewertung
Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AstraZeneca PLC LSE:AZN |
184,75 Mrd. | 10,83 % | 5/6 | 1,37 % | -5,87 % | 13,91 % | UP |
|
Pfizer NYSE:PFE |
139,69 Mrd. | 2,34 % | 4/6 | -0,62 % | 36,63 % | 13,96 % | DOWN |
|
Airbnb NasdaqGS:ABNB |
75,56 Mrd. | 0,00 % | 0/0 | 2,92 % | -257,11 % | 13,44 % | DOWN |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
61,52 Mrd. | 54,83 % | 4/6 | 55,65 % | -56,08 % | -4,33 % | UP |
|
Takeda Pharmaceutical Company TSE:4502 |
7.100,82 Mrd. | 10,31 % | 4/6 | 44,96 % | -2,52 % | 12,19 % | UP |
|
argenx ENXTBR:ARGX |
40,14 Mrd. | 78,67 % | 3/6 | 60,63 % | 38,31 % | 6,79 % | UP |
|
Teva Pharmaceutical Industries NYSE:TEVA |
22,45 Mrd. | -0,24 % | 4/6 | 2,86 % | -99,71 % | 17,53 % | UP |
|
Genmab A/S CPSE:GMAB |
108,89 Mrd. | 31,17 % | 5/6 | -2,58 % | 62,09 % | 10,23 % | UP |
|
Viatris NasdaqGS:VTRS |
11,94 Mrd. | -10,47 % | 3/6 | -9,88 % | -6,73 % | 7,42 % | UP |
|
Ipsen ENXTPA:IPN |
9,70 Mrd. | 7,23 % | 6/6 | 7,49 % | 1,82 % | 2,72 % | UP |
|
Orion Oyj HLSE:ORNBV |
9,29 Mrd. | 9,22 % | 4/6 | 22,62 % | -1,28 % | 14,89 % | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
7,55 Mrd. | 10,33 % | 6/6 | 11,37 % | -86,24 % | 91,99 % | UP |
|
ALK-Abelló A/S CPSE:ALK B |
45,43 Mrd. | 41,77 % | 5/6 | 30,92 % | 18,03 % | -9,93 % | UP |
|
Churchill Downs NasdaqGS:CHDN |
6,77 Mrd. | 19,34 % | 6/6 | 5,24 % | 43,82 % | 37,72 % | DOWN |
|
H. Lundbeck A/S CPSE:HLUN B |
39,94 Mrd. | 22,69 % | 5/5 | 3,68 % | 2,89 % | 7,66 % | UP |
|
Hikma Pharmaceuticals PLC LSE:HIK |
3,69 Mrd. | 3,94 % | 4/6 | -3,65 % | 15,78 % | 50,84 % | DOWN |
|
Zealand Pharma A/S CPSE:ZEAL |
29,76 Mrd. | -5,03 % | 2/6 | 0,00 % | 0,00 % | 100,99 % | DOWN |
|
Indivior PLC LSE:INDV |
3,08 Mrd. | 4,74 % | 5/6 | -9,19 % | -113,07 % | -16,18 % | UP |
|
Virbac ENXTPA:VIRP |
2,72 Mrd. | 13,75 % | 5/6 | 4,92 % | 13,75 % | 23,08 % | DOWN |
|
PENN Entertainment NasdaqGS:PENN |
2,82 Mrd. | -24,10 % | 0/6 | 222,80 % | -16,02 % | 9,45 % | UP |
